A screening method for the ALK fusion gene in NSCLC
Lung cancer research has recently made significant progress in understanding the molecular pathogenesis and even the treatment of lung cancer. Such achievements are directly utilized in clinical practice. Indeed, the EML4-ALK fusion in non-small cell lung cancer (NSCLC) was first described in 2007,...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2012-03-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00024/full |